Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Drew Hope

Drew Hope

Director, Quality Operations, Autolus

Drew Hope joined Autolus in March 2018 as Director of Quality Operations. Autolus is a CAR T-cell company based in London with a portfolio of products in clinical development. Drew is a member of the Scientific Advisory Board of the Advanced-Therapy Manufacturing Community (amc) and former deputy chairman of the Manufacturing Advisory Committee of the BioIndustry Association. Before joining Autolus, Drew was the Head of Advanced Therapy Quality in Guy’s and St Thomas’ NHS Foundation Trust, working on a variety of cell and gene therapy products. Drew studied neurodegenerative diseases using cell modelling during his PhD at University College London and Post Doc at the Mayo Clinic, Jacksonville, and worked as a Regulation Manager in the Human Tissue Authority.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd